Benedetta Peruzzi
Affiliations: | 2004-2006 | Urologic Oncology Branch | National Cancer Institue-NIH |
| 2007- | Azienda Ospedaliero Universitaria Careggi |
Google:
"Benedetta Peruzzi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald P Bottaro | post-doc | 2004-2006 | Azienda Ospedaliero Universitaria Careggi |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mazzoni A, Salvati L, Maggi L, et al. (2020) Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. The Journal of Clinical Investigation. 130: 4694-4703 |
| Buoro S, Peruzzi B, Fanelli A, et al. (2018) Two-site evaluation of the diagnostic performance of the Sysmex XN Body Fluid (BF) module for cell count and differential in Cerebrospinal Fluid. International Journal of Laboratory Hematology. 40: 26-33 |
| Cavone L, Felici R, Lapucci A, et al. (2015) Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. Brain, Behavior, and Immunity. 50: 78-86 |
| Cecchi F, Pajalunga D, Fowler CA, et al. (2012) Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell. 22: 250-62 |
| Cecchi F, Pajalunga D, Fowler A, et al. (2011) A hepatocyte growth factor antagonist engineered by site-directed mutagenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10528 |
| Peruzzi B, Araten DJ, Notaro R, et al. (2010) The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutation Research. 705: 3-10 |
| Cecchi F, Pajalunga D, Rabe DC, et al. (2010) Abstract 342: A hepatocyte growth factor antagonist engineered by disruption of heparan sulfate binding Cancer Research. 70: 342-342 |
| Giubellino A, Shi ZD, Jenkins LM, et al. (2008) Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist. Journal of Medicinal Chemistry. 51: 7459-68 |
| Peruzzi B, Bottaro DP. (2006) Beta-catenin signaling: linking renal cell carcinoma and polycystic kidney disease. Cell Cycle (Georgetown, Tex.). 5: 2839-41 |
| Peruzzi B, Athauda G, Bottaro DP. (2006) The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 14531-6 |